KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Capital Expenditures (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Capital Expenditures data on record, last reported at $29.4 million in Q4 2025.

  • For Q4 2025, Capital Expenditures fell 73.37% year-over-year to $29.4 million; the TTM value through Dec 2025 reached $124.7 million, up 3.1%, while the annual FY2025 figure was $124.7 million, 3.1% up from the prior year.
  • Capital Expenditures reached $29.4 million in Q4 2025 per IDXX's latest filing, down from $86.8 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $129.2 million in Q4 2022 and bottomed at -$24.1 million in Q2 2023.
  • Average Capital Expenditures over 5 years is $32.4 million, with a median of $30.1 million recorded in 2024.
  • Peak YoY movement for Capital Expenditures: tumbled 159.47% in 2022, then skyrocketed 4066.2% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $31.8 million in 2021, then surged by 306.37% to $129.2 million in 2022, then dropped by 5.32% to $122.3 million in 2023, then dropped by 9.64% to $110.5 million in 2024, then plummeted by 73.37% to $29.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $29.4 million in Q4 2025, $86.8 million in Q3 2025, and -$21.6 million in Q2 2025.